PE-backed Junshi Biosciences shines on Star Market debut
PE-backed Junshi Biosciences has become the first Chinese biotech company to list in Hong Kong and the mainland, following a strong debut on Shanghai's Star Market.
Junshi, which counts Loyal Valley Capital and Hillhouse Capital among its investors, raised RMB4.83 billion ($691 million) in its IPO, selling 87 million shares at RMB55.5 apiece. The stock opened...
More on Healthcare
Latest News
China EV battery maker raises $542m Series A
Svolt Energy Technology, formerly the battery business unit of Chinese automaker Great Wall Motor, has raised a RMB3.5 billion ($542 million) Series A round featuring a string of government-linked investors.
Tiger leads $100m Series C for India's Infra.Market
Tiger Global Management has led a $100 million Series C round for India’s Infra.Market, valuing the construction materials marketplace at $1 billion.
VCs flock to Chinese chip designer Moore Threads
Moore Threads, a Chinese chip designer established as recently as last October by a team from Nvidia, has closed two funding rounds amounting to several billion renminbi.
FountainVest buys China logistics business
FountainVest Partners has agreed to acquire a majority stake in China-based CJ Rokin Logistics from Korea’s CJ Logistics for KRW733.8 billion ($661.3 million).